The market moved up jeudi, and Hovedindeksen (OSEBX) ended at 1465 points, which is an increase of 0.9 percent. L'indice thereby reached a new all time high for the 23. time this year. L'indice triggered a buy signal by the break up through the resistance at 1464 points in formation rectangulaire. A further increase to 1523 points within seven months is indicated. 121 shares showed a gain and 150 showed a loss. 34 shares were unchanged and closed at the same price as the previous day. There was no trading in 22 shares. Total value of the trading volume for shares and primary capital certificates jeudi was approximately 6.3 billion. | |
Equinor (EQNR) moved up and ended at 278 kroner, which is an increase of 2.7 percent. L'action has not closed higher since octobre 4. L'action broke up through the resistance at 272 kroner in formation rectangulaire. This triggered a buy signal on increasing volume and a further increase to 304 kroner within seven months is indicated.
BerGenBio (BGBIO) closed at 10.37 kroner after a gain of 29.4 percent. L'action therby broke above the 10.00 -mark for the first time since octobre 10. This past week l'action has gained as much as 68.9 percent. L'action is trend wise negative in the medium term.
Cool Company (CLCO) crashed and ended the day at 102 kroner, which is a drop of 12.9 percent. L'action has never lost more in one day since we started measuring this février 22. 2022. L'action broke down through the support at 107 kroner in formation rectangulaire. This triggered a sell signal on increasing volume and a further drop to 92.13 kroner within seven months is indicated. It was also high volume. Overall it was traded for 37 millions kroner in l'action, which is six times as much as normal daily turnover.
Solstad Offshore (SOFF) was up 3.0 percent to close at 33.00 kroner. L'action triggered a buy signal by the break up through the resistance at 32.82 kroner in formation tête-épaules inversée. A further increase to 37.81 kroner within three months is indicated. It was also high volume. Overall it was traded for 22 millions kroner in l'action, which is three times as much as normal daily turnover.
Thor Medical ASA (TRMED) soared and ended at 2.94 kroner, which is a rise of 24.4 percent. L'action has now risen for the eighth day in a row and this past week l'action has gained as much as 77.2 percent. It also looks good technically. L'action is trend wise positive in the medium term, has support at 1.66 kroner and a further increase is indicated.
|
BerGenBio | 29.37% |
Thor Medical ASA | 24.36% |
Lokotech Group | 7.79% |
Aega | 4.71% |
Cambi | 4.17% |
Aker Horizons | -13.28% |
Cool Company | -12.87% |
Argeo ASA | -9.29% |
EAM Solar | -7.40% |
Golden Ocean Group | -6.24% |
Equinor | 1102.44 |
DOF Group ASA | 404.14 |
Kongsberg Gruppen | 374.89 |
Vår Energi | 292.69 |
DNB Bank | 281.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.